| TabularQual:一种用于在 SBML-qual 中标注和整理逻辑模型的基于电子表格的格式 |
31203 |
查看 |
06/11/2026 - 03:12 |
| Talin-1决定小鼠原代中性粒细胞在体内迁移的方向 |
30870 |
查看 |
06/18/2026 - 21:03 |
| Talin控制黏着斑中vinculin张力的空间分布 |
30550 |
查看 |
06/21/2026 - 10:36 |
| Tamra Picolyl叠氮化物,1毫克 |
6994 |
查看 |
02/19/2026 - 11:50 |
| Tamra Picolyl叠氮化物,25毫克 |
7139 |
查看 |
04/26/2026 - 11:23 |
| Tamra Picolyl叠氮化物,5毫克 |
7138 |
查看 |
04/16/2026 - 01:44 |
| Tamra-alazide-desthio生物素,25毫克 |
7141 |
查看 |
06/21/2026 - 15:43 |
| Tamra-alazide-desthio生物素,5毫克 |
6997 |
查看 |
06/17/2026 - 13:51 |
| Tamra-antabactin Aba受体拮抗剂(Tamra-ant) |
6995 |
查看 |
05/18/2026 - 11:31 |
| Tamra-arazide-生物素,25毫克 |
7140 |
查看 |
06/01/2026 - 16:56 |
| Tamra-arazide-生物素,5毫克 |
6996 |
查看 |
04/27/2026 - 23:08 |
| Tamra叠氮化物,5-异构体,100μl,dmso 10 mm |
6992 |
查看 |
05/08/2025 - 01:03 |
| Tamra叠氮化物,5-异构体,10毫克 |
7131 |
查看 |
04/27/2025 - 05:47 |
| Tamra叠氮化物,5-异构体,1毫克 |
6991 |
查看 |
06/19/2026 - 17:40 |
| Tamra叠氮化物,5-异构体,25毫克 |
7132 |
查看 |
04/06/2026 - 17:03 |
| Tamra叠氮化物,5-异构体,500μl,dmso 10 mm |
7134 |
查看 |
06/17/2026 - 18:56 |
| Tamra叠氮化物,5-异构体,50毫克 |
7133 |
查看 |
04/10/2026 - 10:26 |
| Tamra叠氮化物,5-异构体,5毫克 |
7130 |
查看 |
06/19/2025 - 07:10 |
| Tamra叠氮化物,5异构体,1ml,DMSO 10mm |
7135 |
查看 |
11/16/2024 - 18:52 |
| Tamra甲基四嗪,1毫克 |
7137 |
查看 |
06/17/2026 - 18:18 |
| Tamra甲基四嗪,25毫克 |
7136 |
查看 |
06/16/2026 - 21:45 |
| Tamra甲基四嗪,5毫克 |
6993 |
查看 |
04/26/2026 - 11:14 |
| Tan,L., Li,X., Liu,F., Sun,X., Li,C., Zhu,Z., Fu,Y., Cai,H., Wang,X., Xie,D*. and Sun.C. Control of a key transition from prostrate to erect growth in rice domestication. Nature Genetics 40:1360-4, 20 |
991 |
查看 |
06/03/2026 - 00:50 |
| Tang YP, Shimizu E, Dube GR, Rampon C, Kerchner GA, Zhuo M, Liu G, Tsien JZ. Genetic enhancement of learning and memory in mice. NATURE 401:63-69, 1999 |
1054 |
查看 |
05/29/2026 - 14:23 |
| Tao MA, Li LIU, Hai XUE, Li LI, Chunyan HAN, Lin WANG, Zhiwei CHEN, Gang LIU*, The Chemical Library and Structure-Activity Relationship of Calanolide-A Analogues against HIV-1, Journal of Medicinal Chemistry, 2008, 51, 1432–1446. |
1061 |
查看 |
04/16/2026 - 18:53 |
| Targeted antisense oligonucleotide treatment rescues developmental alterations in spinal muscular atrophy organoids |
30360 |
查看 |
05/10/2026 - 22:00 |
| Targeting ECM-producing cells with CAR-T therapy alleviates fibrosis in chronic kidney disease. |
29873 |
查看 |
06/17/2026 - 16:00 |
| Targeting EGFR-REM2-Ca(2+) signaling and LDHA: amphiregulin remodels energy metabolism to enhance aged embryo development |
30287 |
查看 |
06/12/2026 - 11:50 |
| Targeting MondoA-TXNIP restores antitumour immunity in lactic-acid-induced immunosuppressive microenvironment. |
29872 |
查看 |
12/30/2025 - 16:59 |
| Tau聚集体复制发生于培养人神经元的突触前,并在施用TNFα后增加 |
31153 |
查看 |
06/18/2026 - 16:46 |
| TaxoFormer:用于预测蛋白质序列完整分类谱系的层次化Transformer |
31952 |
查看 |
06/12/2026 - 02:32 |
| TA系统无抗筛选应用研究实现成果转化 |
23428 |
查看 |
04/15/2026 - 07:39 |
| TBS缓冲液(0.05mol/L,PH7.4)(BZ223)1000ml |
3945 |
查看 |
06/15/2026 - 13:44 |
| TBS缓冲液(0.05mol/L,PH7.4)(BZ223)100ml |
3946 |
查看 |
06/20/2026 - 05:41 |
| TBS缓冲液(0.05mol/L,PH7.4)(BZ223)200ml |
3947 |
查看 |
06/10/2026 - 10:25 |
| TBS缓冲液(0.05mol/L,PH7.4)(BZ223)500ml |
3948 |
查看 |
04/15/2026 - 07:42 |
| TCO-NHS酯,1000毫克 |
7145 |
查看 |
04/12/2026 - 23:56 |
| TCO-NHS酯,100毫克 |
7144 |
查看 |
04/15/2026 - 12:35 |
| TCO-NHS酯,25毫克 |
6999 |
查看 |
04/12/2026 - 11:46 |
| TCO-PEG3-马来酰亚胺,100毫克 |
7148 |
查看 |
|
| TCO-PEG3-马来酰亚胺,10毫克 |
7146 |
查看 |
06/20/2026 - 12:55 |
| TCO-PEG3-马来酰亚胺,25毫克 |
7147 |
查看 |
05/25/2025 - 23:11 |
| TCO-PEG3-马来酰亚胺,4×2毫克 |
7000 |
查看 |
06/21/2026 - 03:01 |
| TCO-PEG4-NHS酯,100毫克 |
7153 |
查看 |
04/26/2026 - 08:08 |
| TCO-PEG4-NHS酯,10毫克 |
7151 |
查看 |
04/11/2026 - 04:19 |
| TCO-PEG4-NHS酯,25毫克 |
7152 |
查看 |
10/01/2025 - 02:33 |
| TCO-PEG4-NHS酯,4×2毫克 |
7002 |
查看 |
04/12/2026 - 19:31 |
| TCO-PEG4-酸,100毫克 |
7149 |
查看 |
06/12/2025 - 09:39 |
| TCO-PEG4-酸,25毫克 |
7001 |
查看 |
05/11/2026 - 00:07 |
| TCO-PEG4-酸,500毫克 |
7150 |
查看 |
05/08/2026 - 13:42 |